Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
BMC Psychiatry
|
July 6, 2021
Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)
Lumbini Azim, Paul Hindmarch, Georgiana Browne, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
March 1, 2019
Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition - CORRIGENDUM
Diego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition
Diego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
BMJ Open
|
March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocol
Lumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Health Technology Assessment (Winchester, England)
|
June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial
Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)
R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
The Lancet. Psychiatry
|
July 2, 2025
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK
Michael Browning, Philip J Cowen, Ushma Galal, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 6, 2019
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)
Takahiro Soda, Declan M McLoughlin, Scott R Clark, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 9, 2025
The value of mental science: we publish what matters
Gin S Malhi, Katherine Adlington, Adam Al-Diwani, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
BMC Psychiatry
|
July 6, 2021
Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)
Lumbini Azim, Paul Hindmarch, Georgiana Browne, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
March 1, 2019
Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition - CORRIGENDUM
Diego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition
Diego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
BMJ Open
|
March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocol
Lumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Health Technology Assessment (Winchester, England)
|
June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial
Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)
R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
The Lancet. Psychiatry
|
July 2, 2025
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK
Michael Browning, Philip J Cowen, Ushma Galal, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 6, 2019
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)
Takahiro Soda, Declan M McLoughlin, Scott R Clark, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 9, 2025
The value of mental science: we publish what matters
Gin S Malhi, Katherine Adlington, Adam Al-Diwani, et al.
Page
of 15